Doroshow JH - Search Results

1

HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial.

Lara PN Jr, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Kauderer C, Tichauer G, Twardowski P, Doroshow JH, Gandara DR. Lara PN Jr, et al. Among authors: doroshow jh. Cancer. 2002 May 15;94(10):2584-9. doi: 10.1002/cncr.10526. Cancer. 2002. PMID: 12173324 Free article. Clinical Trial.

2

Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen.

Gandara DR, Wold H, Perez EA, Deisseroth AB, Doroshow J, Meyers F, McWhirter K, Hannigan J, De Gregorio MW. Gandara DR, et al. J Natl Cancer Inst. 1989 May 10;81(10):790-4. doi: 10.1093/jnci/81.10.790. J Natl Cancer Inst. 1989. PMID: 2541260

3

Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial.

Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M, Doroshow JH, Balcerzak SP, Appelbaum FR. Welborn JL, et al. Among authors: doroshow jh. Leukemia. 1995 Jul;9(7):1126-9. Leukemia. 1995. PMID: 7630183 Clinical Trial.

4

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.

Leichman CG, Fleming TR, Muggia FM, Tangen CM, Ardalan B, Doroshow JH, Meyers FJ, Holcombe RF, Weiss GR, Mangalik A, et al. Leichman CG, et al. Among authors: doroshow jh. J Clin Oncol. 1995 Jun;13(6):1303-11. doi: 10.1200/JCO.1995.13.6.1303. J Clin Oncol. 1995. PMID: 7751875 Clinical Trial.

5

Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.

Lau DH, Ryu JK, Gandara DR, Morgan R, Doroshow J, Wilder R, Leigh B. Lau DH, et al. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-106-S12-109. Semin Oncol. 1997. PMID: 9331132 Clinical Trial.

6

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

7

Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer.

Edelman MJ, Meyers FJ, Grennan T, Lauder J, Doroshow J. Edelman MJ, et al. Invest New Drugs. 1998;16(2):179-82. doi: 10.1023/a:1006097109088. Invest New Drugs. 1998. PMID: 9848583 Clinical Trial.

8

Concurrent twice-weekly paclitaxel and thoracic irradiation for stage III non-small cell lung cancer.

Lau D, Ryu J, Gandara D, Morgan R, Doroshow J, Wilder R, Leigh B. Lau D, et al. Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):117-20. Semin Radiat Oncol. 1999. PMID: 10210550 Clinical Trial.

9

Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.

Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J. Lau D, et al. J Clin Oncol. 2001 Jan 15;19(2):442-7. doi: 10.1200/JCO.2001.19.2.442. J Clin Oncol. 2001. PMID: 11208837 Clinical Trial.

10

Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.

Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Raschko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. Tetef ML, et al. Among authors: doroshow jh. Clin Cancer Res. 2001 Jun;7(6):1569-76. Clin Cancer Res. 2001. PMID: 11410492 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

481 results

Search Page

Filters